5.4 Economic evaluation in public health

Economic evaluation in public health helps decision-makers allocate limited resources efficiently. It compares costs and outcomes of different interventions, using methods like cost-effectiveness, cost-benefit, and cost-utility analyses to assess value for money.

These tools inform policy by measuring direct and indirect costs, health outcomes, and long-term impacts. They consider equity, ethics, and real-world implementation, providing crucial evidence for prioritizing public health initiatives and maximizing population health benefits.

Economic Evaluation in Public Health

Defining Economic Evaluation

• Economic evaluation systematically compares costs and consequences of alternative courses of action in healthcare and public health interventions
• Informs decision-makers about efficient allocation of limited resources in public health
• Helps policymakers prioritize interventions by assessing relative value for money and potential impact on population health outcomes
• Includes identifying, measuring, and valuing costs and health outcomes associated with different interventions or programs
• Provides framework for considering opportunity costs representing value of next best alternative use of resources
• Supports evidence-based decision-making in public health policy, program planning, and resource allocation

Components and Applications

• Analyzes both direct costs (medical expenses) and indirect costs (productivity losses)
• Considers short-term and long-term health outcomes (reduced mortality, improved quality of life)
• Applies to various public health interventions (vaccination programs, smoking cessation initiatives)
• Utilizes epidemiological data and economic modeling techniques
• Incorporates sensitivity analyses to account for uncertainties in data and assumptions
• Addresses equity considerations in resource allocation decisions

Cost-Effectiveness vs Cost-Benefit vs Cost-Utility Analyses

Cost-Effectiveness Analysis (CEA)

• Compares relative costs and health outcomes of different interventions
• Measures outcomes in natural units (life years gained, cases prevented)
• Expresses results as incremental cost-effectiveness ratio (ICER)
• Calculates ICER using formula: $ICER = \frac{Cost_{new} - Cost_{current}}{Effect_{new} - Effect_{current}}$
• Suitable for comparing interventions with similar health outcomes
• Examples: comparing two different flu vaccination strategies, evaluating cancer screening programs

Cost-Benefit Analysis (CBA)

• Measures both costs and outcomes in monetary terms
• Allows direct comparison of intervention's benefits to its costs
• Presents results as benefit-cost ratio or net present value
• Calculates net present value using formula: $NPV = \sum_{t=0}^{T} \frac{B_t - C_t}{(1+r)^t}$ Where B_t = benefits in year t, C_t = costs in year t, r = discount rate, T = time horizon
• Useful for interventions with diverse outcomes beyond health (environmental interventions)
• Examples: evaluating workplace safety programs, assessing air pollution control measures

Cost-Utility Analysis (CUA)

• Specific type of CEA measuring health outcomes in quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs)
• Allows comparison across different health conditions and interventions
• Calculates QALYs using formula: $QALY = \sum_{t=1}^{T} Q_t \times L_t$ Where Q_t = quality of life weight in year t, L_t = life years in year t
• Commonly used in healthcare resource allocation decisions
• Examples: comparing treatments for chronic diseases, evaluating mental health interventions

Applying Economic Evaluation Methods

Designing the Evaluation

• Identify perspective of analysis (societal, healthcare system, individual)
• Develop decision analytic model representing health states and transitions
• Collect data on costs, health outcomes, and probabilities from various sources (clinical trials, observational studies, expert opinion)
• Apply discounting techniques to account for time value of money and future health outcomes
• Conduct sensitivity analyses to assess impact of uncertainty in input parameters

Data Collection and Analysis

• Gather direct medical costs (medications, hospitalizations, procedures)
• Estimate indirect costs (productivity losses, caregiver time)
• Measure health outcomes using appropriate metrics (QALYs, DALYs, disease-specific measures)
• Use statistical methods to analyze data and generate results (Monte Carlo simulations, Markov models)
• Employ software tools for economic modeling (TreeAge, R, Excel)

Addressing Equity and Ethical Considerations

• Consider distributional effects of interventions across different population groups
• Incorporate equity weights to account for disparities in health outcomes
• Assess potential unintended consequences of interventions on vulnerable populations
• Evaluate ethical implications of resource allocation decisions
• Engage stakeholders in the evaluation process to ensure diverse perspectives are considered

Interpreting Economic Evaluations for Policy and Practice

Analyzing Results

• Examine incremental cost-effectiveness ratio (ICER) or benefit-cost ratio
• Compare results to established cost-effectiveness thresholds or willingness-to-pay values
• Assess intervention's value considering both effectiveness and cost
• Evaluate budget impact alongside cost-effectiveness for affordability and feasibility
• Consider generalizability and transferability of results across different settings or populations

Communicating Findings

• Tailor communication of results to diverse stakeholders (policymakers, healthcare providers, public)
• Present findings using clear visualizations (cost-effectiveness planes, tornado diagrams)
• Highlight key assumptions and limitations of the analysis
• Provide context for interpreting results within broader decision-making framework
• Offer recommendations for policy or practice based on economic evaluation findings

Integrating with Other Evidence

• Combine economic evaluation results with clinical effectiveness data
• Consider feasibility of implementation in real-world settings
• Incorporate ethical considerations and societal values
• Assess potential impact on health equity and disparities
• Recognize limitations and potential biases in economic evaluations
• Use results as one component of comprehensive evidence-based decision-making in public health